步长制药子公司拟对外投资490万设立两家合资公司

Group 1 - Company announced an investment of 4.9 million yuan through its subsidiary Shanghai HePu Medical Technology Co., Ltd. to establish two new companies [2] - The registered capital for Shandong HePu RuiCheng Medical Technology Co., Ltd. is 4 million yuan, with Shanghai HePu contributing 2.8 million yuan for a 70% stake [2] - The registered capital for Hubei HePu Medical Technology Co., Ltd. is 3 million yuan, with Shanghai HePu contributing 2.1 million yuan for a 70% stake [2] Group 2 - Company’s revenue projections for 2024 and Q2 2025 are 11.006 billion yuan and 2.785 billion yuan, with year-on-year changes of -16.91% and 5.47% respectively [3] - The net profit attributable to shareholders for the same periods is projected at -554 million yuan, 307 million yuan, and 628 million yuan, with year-on-year growth rates of -273.62%, 169.49%, and 171.24% respectively [3] - The company's asset-liability ratios for the periods are 49.26%, 49.33%, and 48.53% [3]